Your browser doesn't support javascript.
loading
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.
Liu, Jianying; Liu, Yang; Xia, Hongjie; Zou, Jing; Weaver, Scott C; Swanson, Kena A; Cai, Hui; Cutler, Mark; Cooper, David; Muik, Alexander; Jansen, Kathrin U; Sahin, Ugur; Xie, Xuping; Dormitzer, Philip R; Shi, Pei-Yong.
  • Liu J; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Liu Y; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
  • Xia H; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
  • Zou J; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
  • Weaver SC; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
  • Swanson KA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • Cai H; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
  • Cutler M; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA.
  • Cooper D; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.
  • Muik A; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.
  • Jansen KU; Pfizer Vaccine Research and Development, Pearl River, NY, USA.
  • Sahin U; Pfizer Vaccine Research and Development, Pearl River, NY, USA.
  • Xie X; Pfizer Vaccine Research and Development, Pearl River, NY, USA.
  • Dormitzer PR; Pfizer Vaccine Research and Development, Pearl River, NY, USA.
  • Shi PY; BioNTech, Mainz, Germany.
Nature ; 596(7871): 273-275, 2021 08.
Article en En | MEDLINE | ID: mdl-34111888

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pruebas de Neutralización / Anticuerpos Neutralizantes / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pruebas de Neutralización / Anticuerpos Neutralizantes / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article